Skip to main content

Advertisement

Log in

12-Lipoxygenase Induces Apoptosis of Human Gastric Cancer AGS Cells via the ERK1/2 Signal Pathway

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

12-Lipoxygenase (12-LOX) is over-expressed in a variety of human tumors, but its exact effect on the tumorogenesis of gastric cancer remains largely obscure. To investigate the effect of 12-LOX and its inhibitor baicalein on proliferation and apoptosis of human gastric cancer, AGS cells were separately treated with 12-hydroxyeicosatetraenoic acid (12-HETE, a metabolite of 12-LOX) and baicalein. MTT assay revealed that the absorbance of the 12-HETE-treated group was significantly (P < 0.01) higher than that of control group and that the absorbance of baicalein-treated group was significantly (P < 0.01) less than that of the control group, and that 48 h after treatment the apoptosis index of the baicalein-treated group was significantly (P < 0.01) higher than that of the untreated group and was significantly (P < 0.01) lower in the 12-HETE-treated group. Western blotting analysis was used to investigate the mechanism of these effects. The results revealed that the concentration of phosphorylated ERK in cells treated with 100 nmol L−1 12-HETE was significantly (P < 0.05) higher than in the untreated group and that the concentration of phosphorylated ERK1/2 in cells treated with 40 μmol L−1 baicalein was significantly (P < 0.05) lower than in the untreated group. The expression level of bcl-2 was up-regulated and down-regulated after separate treatment with 12-HETE and baicalein, respectively, and both of these effects could be blocked by PD98059. Protein kinase C (PKC) activity was increased by treatment with 12-HETE and reduced by treatment with baicalein (P < 0.05). The PKC inhibitor BIM (bisindolymaleimide-I) blocked the phosphorylation of ERK1/2 and activation of PKC induced by 12-LOX. When pretreated with BIM, the concentration of phospho-ERK1/2 or bcl-2 in the BIM + 12-HETE-treated group was significantly (P < 0.05) lower than in that treated with 12-HETE only, and the concentration in the BIM + baicalein-treated group was significantly (P < 0.05) higher than in that treated with baicalein only. On the basis of these data we conclude that, via its metabolite 12-HETE, 12-LOX abolishes proliferation of AGS cells and protect cells from apoptosis by activating the ERK1/2 pathway and, eventually, enhances expression of bcl-2. Because PKC is also involved in the activation of ERK1/2 induced by 12-LOX, 12-LOX inhibitors would be potentially powerful anticancer agents for prevention and cure of human gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Pidgeon GP, Kandouz M, Meram A, Honn KV (2002) Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 62:2721–2727

    PubMed  CAS  Google Scholar 

  2. Chen YQ, Duniec ZM, Liu B, Hagmann W, Gao X, Shimoji K et al (1994) Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res 54:1574–1579

    PubMed  CAS  Google Scholar 

  3. Hong SH, Avis I, Vos MD, Martinez A, Treston AM, Mulshine JL (1999) Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res 59:2223–2228

    PubMed  CAS  Google Scholar 

  4. Szekeres CK, Tang K, Trikha M, Honn KV (2000) Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells. J Biol Chem 275:38831–38841

    Article  PubMed  CAS  Google Scholar 

  5. Liu N, Sun LG, Yu HY, Zhang Y, Yang Q, Wang XP (2005) The function of ERK on Fas-mediated apoptotic signaling pathway of human gastric carcinoma cells. Zhonghua Zhong Liu Za Zhi 27:201–203

    PubMed  Google Scholar 

  6. Zhang JJ, Okutani F, Inoue S, Kaba H (2003) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway leading to cyclic AMP response element-binding protein phosphorylation is required for the long-term facilitation process of aversive olfactory learning in young rats. Neuroscience 121:9–16

    Article  PubMed  CAS  Google Scholar 

  7. Rosenblum K, Futter M, Jones M, Hulme EC, Bliss TV (2000) ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J Neurosci 20:977–985

    PubMed  CAS  Google Scholar 

  8. Tang DG, Tarrien M, Dobrzynski P, Honn KV (1995) Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C- and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK). J Cell Physiol 162:291–306

    Article  Google Scholar 

  9. Damdinsuren B, Nagano H, Sakon M, Kondo M, Yamamoto T, Umeshita K, Dono K, Nakamori S, Monden M (2003) Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs. Ann Surg Oncol 10:1184–1190

    Article  PubMed  Google Scholar 

  10. Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT (2000) Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism. J Hypertens 18:209–215

    Article  PubMed  CAS  Google Scholar 

  11. Hamilton SE, Nathanson NM (2001) The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J Biol Chem 276:15850–15853

    Article  PubMed  CAS  Google Scholar 

  12. Pidgeon GP, Tang K, Cai YL, Piasentin E, Honn KV (2003) Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3), alpha(v)beta(5) integrin expression. Cancer Res 63:425842–425867

    Google Scholar 

  13. Nie D, Nemeth J, Qiao Y, Zacharek A, Li L, Hanna K et al (2003) Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin Exp Metastasis 20:657–663

    Article  PubMed  CAS  Google Scholar 

  14. Tong WG, Ding XZ, Adrian TE (2002) The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem Biophys Res Commun 296:942–948

    Article  PubMed  CAS  Google Scholar 

  15. Ikemoto S, Sugimura K, Kuratukuri K, Nakatani T (2004) Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2). Anticancer Res 24:733–736

    PubMed  CAS  Google Scholar 

  16. Chang WH, Chen CH, Gau RJ, Lin CC, Tsai CL, Tsai K et al (2002) Effect of baicalein on apoptosis of the human Hep G2 cell line was induced by mitochondrial dysfunction. Planta Med 68:302–306

    Article  CAS  Google Scholar 

  17. Tong WG, Ding XZ, Witt RC, Adrian TE (2002) Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1:929–935

    PubMed  CAS  Google Scholar 

  18. Lee HZ, Leung HW, Lai MY, Wu CH (2005) Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25:959–964

    PubMed  CAS  Google Scholar 

  19. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609–619

    Article  PubMed  CAS  Google Scholar 

  20. Liu ZJ, Lin QX, Wang QY, Lin HH, Luo XL, Zham DJ (2000) Relationship between the expression of bcl-2/bax gene and cell apoptosis and proliferation in gastric cancer and its pre-cancerous lesions. Ai zheng 19:999–1000

    Google Scholar 

  21. Wong BC, Wang WP, Cho CH, Fan XM, Lin MC, Kung HF, Lam SK (2001) 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis 22:1349–1354

    Article  PubMed  CAS  Google Scholar 

  22. Li JL, Zhu JH, Jing ZZ, Chen ZC, Xiao ZQ (2003) G-protein-coupled muscarinic acetylcholine receptor activation up-regulates bcl-2 and phospho-bad via Ras-ERK-1/2 signaling pathway. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 35:41–48

    PubMed  CAS  Google Scholar 

  23. Iwase T, Tanaka M, Suzuki M, Naito Y, Sugimura H, Kino I (1993) Identification of protein-tyrosine kinase genes preferentially expressed in embryo stomach and gastric cancer. Biochem Biophys Res Commun 194:698–705

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China (Grant30300154) and Education Foundation of Fujian Province (Grant JA03094).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Feng-Lin Chen or Xiao-Zhong Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, FL., Wang, XZ., Li, JY. et al. 12-Lipoxygenase Induces Apoptosis of Human Gastric Cancer AGS Cells via the ERK1/2 Signal Pathway. Dig Dis Sci 53, 181–187 (2008). https://doi.org/10.1007/s10620-007-9841-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-9841-1

Keywords

Navigation